Vimarsana
Biggest News Aggregation in the World

Page 17 - Ancer Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Prostate Today - Breaking & Trending Today

'Cancer' Label for Low-Risk Prostate Lesions? Patients Split - Vimarsana News

'Cancer' Label for Low-Risk Prostate Lesions? Patients Split

But pathologists largely think the name should stay, results of a recent survey show.

New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer - Vimarsana News

New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer

Radiolabeled 89Zr-DFO-girentuximab PET/CT can accurately and noninvasively identify clear cell renal carcinoma, with minimal toxicity, say researchers reporting results from the phase 3 ZIRCON trial.

Talazoparib Add-On Improves Outcomes in Metastatic Prostate Cancer - Vimarsana News

Talazoparib Add-On Improves Outcomes in Metastatic Prostate Cancer

For patients with metastatic castration-resistant prostate cancer, talazoparib combined with enzalutamide achieved better progression-free survival than enzalutamide alone.

Rucaparib Benefit in BRCA+ Prostate Cancer Confirmed - Vimarsana News

Rucaparib Benefit in BRCA+ Prostate Cancer Confirmed

For patients with metastatic castration-resistant prostate cancer with BRCA alterations, rucaparib doubled progression-free survival as compared with docetaxel, abiraterone, or enzalutamide.

Are Repeat Radiographs Necessary in RA and PsA? - Vimarsana News

Are Repeat Radiographs Necessary in RA and PsA?

"If a patient doesn't achieve remission or very low disease activity, obtaining a radiograph doesn't change what you do … you're going to make a change anyway," Dr. Roy Fleischmann said.